PIK3R2 Antibody

1. Data indicate that miR-126 overexpression in RASFs inhibits PIK3R2 expression and promotes proliferation while inhibiting apoptosis. PMID:27729613
2. this study shows that targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma PMID:27835880
3. Data show that phosphoinositol-3 kinase regulatory subunit 2 (PIK3R2) mRNA is a direct target of miR-126-3p. PMID:27191494
4. Data indicate that miR-126 expression negatively correlates with p85beta in CLL patients and that miR-126 can effectively target p85beta in a cell-line system. PMID:28299881
5. Mosaic mutations in PIK3CA or PIK3R2 which activate class 1A PI3K cause severe non-ketotic hypoglycaemia in a subset of patients, with the metabolic phenotype presumably related to the extent of mosaicism within the liver PMID:28566443
6. PIK3R2 D557H mutation causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia. PMID:26860062
7. miR-3151 silencing by DNA methylation protected chronic lymphocytic leukemia cells from apoptosis by over-expression of its direct targets MADD and PIK3R2, constitutive activation of MEK/ERK and PI3K/AKT signaling , and over-expression of MCL1. PMID:26517243
8. pik3r2 was confirmed to be a direct target of miR126 in prostate cancer. PMID:26677064
9. indicated that miR-126 expression was negatively correlated with PIK3R2 mRNA expression PMID:26723864
10. The miR-126 was found to act as proliferation suppressor targeting PIK3R2 gene and reducing p85beta (a regulatory subunit of PI3K kinase) protein translation and lower AKT kinase activity. PMID:26384552
11. Constitutional and mosaic mutations in the PIK3R2 gene are associated with developmental brain disorders ranging from Bilateral perisylvian polymicrogyria with a normal head size to the megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. PMID:26520804
12. The authors show that this potentiation involves reorganization of the natural CrkL-p85beta complex into a novel trimeric complex where influenza A virus NS1 serves as a bridging factor. PMID:26099693
13. the metastasis and angiogenesis functions of miR-126-3p were mediated by LRP6 and PIK3R2. PMID:25240815
14. Study indicates that miR-126 is a tumor suppressor that inhibits gastric cancer cells proliferation by targeting PI3KR2, Crk and PLK2. PMID:24969300
15. FBXL2 mediates the ubiquitylation and degradation of p85beta on cell membranes. PMID:23604317
16. miR-126-mediated phosphoinositide-3-kinase regulation, not only fine-tunes VEGF-signaling, but it strongly enhances the activities of Ang-1 on vessel stabilization and maturation. PMID:22867989
17. p85beta phosphoinositide 3-kinase subunit regulates tumor progression PMID:22733740
18. recombinant production, crystallization and X-ray structure determination at 2.0 A resolution of the SH3 domain of human p85beta is described PMID:22102226
19. miR-126 could target both VEGFA and PIK3R2, and its expression was decreased in human breast cancer, implying that miR-126 may play a role in tumor genesis and growth by regulating the VEGF/PI3K/AKT signaling pathway PMID:21249429
20. The crystal structure of human p85beta iSH2 determined to 3.3A resolution is reported. PMID:21139197
21. Macropinocytosis is regulated by interactions between Abi1 pY213 and the C-terminal SH2 domain of p85-thereby linking Abl kinase signaling to p85-dependent regulation of macropinocytosis. PMID:20598684
22. Overexpression of SH3 domain of p85beta inhibits influenza A virus replication. PMID:20653952
23. the PTEN phosphatase is active against the PI3K p85beta subunit and dephosphorylates a protein involved in insulin signaling where known downstream consequences are increased cell migration, motility, and invasion. PMID:20515662
24. oncogenic p85 mutations lead to a loss of a C2-iSH2 domain contact that is required for inhibition of p110alpha by p85. PMID:19915146
25. NS5A mediates activation of beta-catenin in a phosphoinositide-3 kinase-dependent fashion. PMID:19846673
26. Mutant viruses carrying NS1 with mutations in SH3 binding motif 1 failed to interact with p85ss and induce the subsequent activation of PI3K/Akt pathway. PMID:17881440
27. in VSMCs exposed to hyperglycemia, IGF-I stimulation of Shc facilitates the transfer of Grb2 to p85 resulting in enhanced PI3K activation and AKT phosphorylation leading to enhanced cell proliferation and migration PMID:18420583

Show More

Hide All

HGNC: 8980

UNIGENE: Hs.371344

KEGG: hsa:5296

STRING: 9606.ENSP00000471914

OMIM: 603157